Non-puerperal lactation associated with antidepressant drug use

British Journal of Clinical Pharmacology

Volumn 44, Issue 3, 1997, Pages 277-281

  Egberts, Antoine C G ^a,b   Meyboom, Ronald H B ^a   De Koning, Fred H P ^a,b   Bakker, Albert ^b   Leufkens, Hubert G M ^b  

^a Netherlands Pharmacovigilance F   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Adverse drug reaction reporting systems; Antidepressant drugs; Non puerperal lactation; Serotonin

Indexed keywords

ANTIDEPRESSANT AGENT; CLOMIPRAMINE; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SURVEILLANCE PROGRAM; FEMALE; GALACTORRHEA; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0030930071     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1997.00652.x     Document Type: Article

References (28)

1. Davies DM. Textbook of adverse drug reactions. Oxford University Press, Oxford 1991: 355-356.
2. Anonymous. International monitoring of adverse reactions to drugs. Adverse reaction terminology. Uppsala, Sweden: WHO Collaborating Centre for International Drug Monitoring, 1995.
3. Finney DJ. Systematic signalling of adverse reactions to drugs. Meth Inform Med 1974; 13: 1-10.
4. Stricker BHCh, Tijssen JGP. Serum sickness-like reactions to cefaclor J Clin Epidemiol 1992; 45: 1177-1184.
5. Richelson E. Pharmacology of antidepressants. Characteristics of the ideal drug. Mayo Clin Proc 1994; 69: 1069-1081.
6. Klein JJ, Segal RL, Warner RR. Galactorrhea due to imipramine. N Engl J Med 1964; 271: 510-512.
7. Rees WD. Lactation and ovarian cyst formation following treatment with amitriptyline. Practitioner 1967; 198: 835-838.
8. Gelenberg AJ, Cooper DS, Doller JC, Maloof F. Galactorrhea and hyperprolactinemia associated with amoxapine therapy. Report of a case. JAMA 1979; 242: 1900-1901.
9. Jaffe K, Zisook S. Galactorrhea in a patient treated with amoxapine. J Clin Psychiatry 1978; 39: 821.
10. Fowlie S, Burton J. Hyperprolactinaemia and nonpuerperal lactation associated with clomipramine. Scot Med J 1987; 32: 52.
11. Anand VS. Clomipramine-induced galactorrhoea and amenorrhoea. Br J Psychiatry 1985; 147: 87-88.
12. Perez OE, Henriquez N. Galactorrhea associated with maprotiline. Am J Psychiatry 1983; 140: 641-642.
13. Gadd EM, Norris CM, Beeley L. Antidepressants and galactorrhoea. Int Clin Psychopharmacol 1987; 2: 361-363.
14. Jeffries J, Bezchlibnyk-Butler K, Remington G. Amenorrhea and galactorrhea associated with fluvoxamine in a loxapinetreated patient. J Clin Psychopharmacol 1992; 12: 296-297.
15. Bonin B, Vandel P, Vandel S. Fluvoxamine and galactorrhea. A case report. Therapie 1994; 49: 149-151.
16. Iancu I, Ratzoni G, Weitzman A, Apter A. More fluoxetine experience. J Am Acad Child Adolesc Psychiatry 1992; 31: 755-756.
17. Arya DK, Taylor WS. Lactation associated with fluoxetine treatment. Aust NZJ Psychiatry 1995; 29: 697.
18. Bronzo MR, Stahl SM. Galactorrhea induced by sertraline. Am J Psychiatry 1993; 150: 1269-1270.
19. Lesaca TG. Sertraline and galactorrhea. J Clin Psychopharmacol 1996; 16: 333-334.
20. Meyboom RH, Assies J, Bemt PM van den, de Koning GHP. Galactorrhea and gynecomastia as side effect of drugs. Ned Tijdschr Ceneeskd 1993; 137: 2498-2503.
21. Tyson JE, Zacur HA. Diagnosis and treatment of abnormal lactation. Clin Obstet Gynecol 1975; 18: 65-93.
22. Frantz AG. Prolactin. N Engl J Med 1978; 298: 201.
23. Tubert-Bitter P, Begaud B. Comparing safety of drugs. Post Marketing Surveillance 1993; 7: 119-137.
24. Inman WHW. Monitoring for drug safety. MTP Press Limited, Lancaster 1985.
25. Barbieri C, Magnoni V, Rauhe WG, Zanasi S, Caldara R, Ferrari C. Effect of fenfluramine on prolactin secretion in obese patients: evidence for serotonergic regulation of prolactin in man. Clin Endocrinol 1983; 19: 705.
26. Arya DK. Extrapyramidal symptoms with selective serotonin reuptake inhibitors. Br J Psychiatry 1994; 165: 728-733.
27. Kapur S, Remington G. Serotonin-dopamine interaction and its relevance to schizophrenia. Am J Psychiatry 1996; 153: 466-476.
28. Muller EE, Locatelli V, Cella S, Penalva A, Novelli A, Cocchi D. Prolactin-lowering and releasing drugs. Drugs 1983; 141: 1023-1025.